Scientists have identified a distinct biochemical fingerprint in the bloodstream that corresponds to how many ultra-processed foods a person eats, and that signature is associated with elevated markers for inflammation, impaired fat metabolism, and heightened chronic disease risk.
The finding, published July 6, 2026 in the peer-reviewed journal Critical Reviews in Food Science and Nutrition, comes from a team led by Dr. Jessica Blanco-Lopez of the International Agency for Research on Cancer (IARC), the cancer research arm of the World Health Organization. It is the largest study of its kind to use targeted metabolomics — the analysis of small molecules in the blood that reflect metabolic processes — to examine what ultra-processed food actually does inside the body.
Why This Matters
For years, researchers have documented statistical associations between ultra-processed food (UPF) consumption and higher rates of cancer, cardiovascular disease, type 2 diabetes, obesity, and early death. But the biological explanation for why those associations exist has remained unclear, which has left room for debate about whether the foods themselves are the problem or whether people who eat more UPFs simply have other unhealthy habits.
This study offers a new level of biological specificity. Rather than asking what people say they eat and then tracking their health outcomes, the IARC team looked directly at the blood and found measurable changes in molecular composition that correlate with higher UPF intake. Those changes suggest mechanisms — metabolic pathways — through which ultra-processed food may harm health.
The findings do not establish that ultra-processed food directly causes disease. But they substantially narrow the distance between association and mechanism, and they represent the clearest biological evidence to date of what happens in the body at higher levels of UPF intake.
What We Know So Far
The research team analyzed blood samples and dietary data from 15,200 adults enrolled in the European Prospective Investigation into Cancer and Nutrition (EPIC) — one of the largest diet and health cohort studies in the world, spanning participants across multiple European countries.
Participants completed detailed dietary questionnaires. Researchers then categorized those diets using the NOVA food classification system, which divides foods into four groups ranging from unprocessed to ultra-processed. Ultra-processed foods in the NOVA system include packaged snacks, flavored yogurts, instant noodles, soft drinks, processed deli meats, and most fast food items.
Using targeted metabolomics, the team then examined blood samples for molecular signatures that correlated with UPF intake. They identified:
- 22 distinct metabolites that differed significantly in adults with higher UPF consumption
- 8 fatty acid markers that were elevated in those eating more UPFs, including types associated with unfavorable cardiovascular and metabolic outcomes
- A metabolic profile consistent with increased systemic inflammation , disrupted lipid (fat) metabolism , and pathways linked to insulin resistance
The study, according to EurekAlert!, is the first to use targeted metabolomics in a large European cohort specifically to investigate what ultra-processed foods do to blood chemistry.
Where the Risk Is Highest in the United States
The EPIC cohort was drawn from European adults, so the specific metabolite findings cannot be automatically applied to U.S. populations. However, research suggests the United States has one of the highest levels of ultra-processed food consumption in the world.
A 2021 analysis published in the American Journal of Clinical Nutrition estimated that ultra-processed foods account for approximately 57% of total caloric intake for U.S. adults. That figure is even higher for children and adolescents.
Ultra-processed food consumption is also unevenly distributed across income levels. Lower-income households — and the urban communities most dependent on convenience and fast food — tend to have higher UPF diets, in part because less-processed alternatives are more expensive and less accessible. This means the metabolic consequences identified in the EPIC study may be disproportionately concentrated in communities that already face elevated chronic disease burdens.
Major metro areas, including Houston, Detroit, Chicago's South Side, the Bronx in New York City, and areas of Los Angeles with limited grocery access, have been repeatedly identified in food access research as having lower availability of fresh, unprocessed foods and higher dependence on convenience-store and fast-food options.
What Doctors and Experts Say
The lead researcher, Dr. Jessica Blanco-Lopez of IARC/WHO, stated in a release published by News-Medical.net: "Our study underscores the potential metabolic impact of UPFs and highlights the need for further research using targeted and untargeted metabolomics approaches to clarify the biological pathways linking food processing with chronic diseases and mortality."
That careful framing reflects the design of this study. It observed people at a single point in time — a cross-sectional design — rather than following them over years. That means researchers could establish that higher UPF consumption and a specific metabolic signature co-occur, but cannot yet confirm that the foods produced the changes, or that the changes lead to disease outcomes in these individuals.
What the findings do add, as News-Medical.net reported, is a more specific biological picture: ultra-processed foods appear to be linked to higher levels of the types of fatty acids associated with inflammation and poor metabolic health. The molecular detail makes this a meaningful advance over prior epidemiological research.
Nutrition researchers not affiliated with the study have noted that the metabolomics approach is significant because it moves the science away from self-reported dietary data — which is inherently imprecise — toward objective biological markers. That methodological improvement strengthens confidence in the underlying association, even as causation remains to be confirmed through longitudinal research.
What the Evidence Shows and What It Does Not
MedicalDaily Evidence Check
- Study type: Cross-sectional metabolomics analysis within a large prospective cohort (EPIC)
- Participants: 15,200 European adults
- Published in: Critical Reviews in Food Science and Nutrition , July 2026 ( DOI: 10.1080/10408398.2026.2629025 )
- What it found: Higher UPF intake is associated with 22 blood metabolites and 8 fatty acid patterns consistent with inflammation and metabolic disruption
- What it did not prove: The study cannot establish that UPFs directly cause these metabolic changes or that those changes lead to specific diseases in these participants; the cross-sectional design captures one point in time, not change over time
- What readers should know: This is the largest targeted metabolomics study of UPF intake to date, and it identifies plausible biological mechanisms — though confirmation requires longitudinal research
This study does not change current dietary guidelines. The 2020–2025 Dietary Guidelines for Americans already recommend limiting added sugars, saturated fats, and sodium — components found in high concentrations in most ultra-processed foods.
Who Faces the Greatest Risk?
Across a broad population, people with the highest ultra-processed food intake face the most significant metabolic impact based on this research. Groups most likely to have high UPF consumption include:
- Adults and children in households with limited grocery store access
- People with lower income who rely more heavily on packaged and convenience foods
- Adults who eat frequently at fast food restaurants
- Those without time to prepare meals at home
- College students and young adults living alone for the first time
Independently of UPF intake, individuals with type 2 diabetes, cardiovascular disease, or obesity already face elevated metabolic risk, and reducing UPF consumption may be particularly relevant as one component of a broader dietary approach discussed with a clinician.
Symptoms and Warning Signs to Watch For
This research does not describe symptoms in the traditional sense — the metabolic changes identified are detectable through blood testing, not by how people feel day-to-day. Inflammation and lipid imbalances often produce no noticeable symptoms in the short term.
However, over time, the chronic conditions associated with high UPF intake — including type 2 diabetes, cardiovascular disease, and obesity — do produce recognizable signs. These may include:
- Persistent fatigue or difficulty with energy levels
- Gradual weight gain that is difficult to reverse with activity changes alone
- Elevated triglycerides or other abnormal lipid values on a routine blood panel
- Elevated fasting blood glucose
- Digestive irregularities, including bloating or discomfort after eating
These are general signals that a conversation with a clinician about diet and metabolic health may be worthwhile — not symptoms that can be attributed specifically to ultra-processed food consumption.
What You Can Do Now
- Review your diet with honesty. Ultra-processed foods are defined not by calories or fat content but by what they contain: industrial additives, emulsifiers, flavor enhancers, and ingredients not typically found in home cooking. Common examples include packaged chips, fast food burgers, flavored instant oatmeal, and sweetened beverages.
- Ask your doctor about a metabolic panel at your next routine visit, including fasting blood glucose, HbA1c, and lipid levels — these can reveal metabolic changes before symptoms develop.
- Prioritize less-processed alternatives where possible. Whole grains, legumes, fresh or frozen vegetables, and minimally processed proteins are associated with better metabolic outcomes in long-term dietary studies.
- Do not eliminate entire food categories without clinical guidance. People managing diabetes, heart disease, or other conditions should discuss dietary changes with their care team before making significant shifts.
- Consult ChooseMyPlate or speak with a registered dietitian for personalized evidence-based dietary guidance.
Cost and Access: What Patients Should Know
One of the genuine barriers to reducing UPF consumption is cost and access. Fresh produce, lean proteins, and whole grains can be more expensive than packaged alternatives — particularly in food deserts and lower-income neighborhoods.
Programs that can help include the USDA Supplemental Nutrition Assistance Program (SNAP), which can be used for a wide range of foods, including fresh produce. The SNAP-Ed program also offers free nutrition education in many states. Community health centers, many of which serve uninsured and underinsured patients, may provide registered dietitian consultations at low or no cost.
What Happens Next
The IARC team indicated that the next research priority is to apply both targeted and untargeted metabolomics approaches to larger and more diverse populations — including non-European cohorts — to determine whether the metabolic signature holds across different dietary contexts and ethnic backgrounds.
Longitudinal studies that follow participants over time, rather than capturing a single point, will be necessary to establish whether the blood changes seen here actually precede and predict disease outcomes. That would significantly strengthen the causal argument.
MedicalDaily will update coverage of this research as follow-up studies emerge.
The Bottom Line
For the first time, researchers have used large-scale blood analysis to show that eating more ultra-processed food leaves a measurable biological signature — one associated with inflammation and disrupted fat metabolism. The study does not prove that ultra-processed food causes disease. But it brings science meaningfully closer to understanding how it might.
For American adults already navigating diabetes, heart disease, or obesity, the findings add weight to existing dietary guidance: limiting ultra-processed food is supported by both epidemiological and now biological evidence. Talk with a clinician about how your current diet compares, and whether a metabolic blood panel is worth discussing at your next visit.
